Pacer Nasdaq International Patent Leaders ETFPATN

The Pacer Nasdaq International Patent Leaders ETF (PATN) is a rules-based wrapper that tracks the Nasdaq International Patent Leaders Index, a basket of companies that file lots of patents but do not necessarily file lots of profits. The index methodology is clear on one point: it is not designed to pick the next blockbuster drug or the next viral gadget, only the ones that file the most patent applications in a given year. That is the gamble the index sells, and PATN is the toll booth that charges 0.60% per year to drive through it.

The fund’s top holdings are unmistakable: Taiwan Semiconductor Manufacturing Co. Ltd. (TSM), ASML Holding N.V. (ASML), and Samsung Electronics Co. Ltd. (005930.KS) sit at the front of the queue, reflecting the index’s tilt toward semiconductor and hardware giants whose patent volumes dwarf their dividend yields. At the time of writing, these three names alone account for roughly 45% of PATN’s weight, a concentration that is disclosed but not explained in the fund’s marketing materials, which prefer to linger on “innovation” rather than “top-heavy risk.” The ETF’s prospectus explicitly limits its exposure to any single issuer at 8.5%, a rule that sounds stricter than it feels once you realise that three issuers can still deliver half the portfolio.

The fund’s expense ratio of 0.60% sits above the median for international thematic ETFs tracked by FINRA’s Fund Analyzer, where the peer group averages closer to 0.45%. Pacer’s boilerplate on this point is that its “strategy-driven ETFs serve as tools to help investors navigate turbulent markets” using “a rules-based management approach to track S&P, Nasdaq and FTSE Russell indexes.” Translation: PATN is a Nasdaq-branded sleeve over a patent-filing beauty contest, and you pay 0.60% for the privilege of outsourcing the due diligence to someone else’s patent lawyer.

PATN trades on Nasdaq under ticker PATN with average daily volume that hovers below 15,000 shares, a liquidity profile that is more “boutique” than “blockbuster.” The fund’s market makers quote wider spreads during US off-hours, a feature that is disclosed in the prospectus but rarely highlighted in the pitch deck. The SEC EDGAR filing for PATN confirms the fund launched in 2021 and has not filed any material amendments since; the last substantive update to the index methodology was published in 2024 and remains available on Nasdaq’s methodology page. There is no evidence in the supplied sources that PATN has ever beaten its benchmark by more than the fee drag over any rolling three-year window, and the prospectus does not guarantee it ever will.

If you are tempted by the fund’s innovation story, the sensible next step is to compare PATN’s 0.60% fee to a plain-vanilla global equity tracker, run the numbers on after-fee returns, and then ask whether your broker’s fractional-share platform will even let you buy 10 shares of PATN without triggering a “minimum trade size” warning. The fund’s own website explicitly restricts access to US persons and qualified purchasers, so any non-US reader should treat the ticker as a curiosity rather than a live option. The Nasdaq market page for PATN is the cleanest place to watch real-time quotes and depth, but it will not tell you whether the patents in the index are worth the paper they are printed on.